Interaction of campylobacter species with antibody, complement and phagocytes. 1989

E Bernatowska, and P Jose, and H Davies, and M Stephenson, and D Webster
Division of Immunological Medicine, Section of Electron Microscopy, Clinical Research Centre, Harrow, Middlesex.

The opsonisation of four different campylobacter species for human neutrophils was studied using a chemiluminescence system and electron microscopy. Opsonisation of Campylobacter fetus, Campylobacter coli, and Campylobacter jejuni was mediated by antibody and enhanced by complement. Antibody was not, however, required for the phagocytosis of Campylobacter pylori because it activates the classical pathway of complement directly. This unusual property may be important in the pathogenesis of C pylori associated gastritis and duodenal ulcer.

UI MeSH Term Description Entries
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D009895 Opsonin Proteins Proteins that bind to particles and cells to increase susceptibility to PHAGOCYTOSIS, especially ANTIBODIES bound to EPITOPES that attach to FC RECEPTORS. COMPLEMENT C3B may also participate. Opsonin,Opsonin Protein,Opsonins,Protein, Opsonin
D010587 Phagocytosis The engulfing and degradation of microorganisms; other cells that are dead, dying, or pathogenic; and foreign particles by phagocytic cells (PHAGOCYTES). Phagocytoses
D002167 Campylobacter A genus of bacteria found in the reproductive organs, intestinal tract, and oral cavity of animals and man. Some species are pathogenic.
D002168 Campylobacter fetus A species of bacteria present in man and many kinds of animals and birds, often causing infertility and/or abortion. Spirillum fetus,Vibrio fetus
D003176 Complement C3 A glycoprotein that is central in both the classical and the alternative pathway of COMPLEMENT ACTIVATION. C3 can be cleaved into COMPLEMENT C3A and COMPLEMENT C3B, spontaneously at low level or by C3 CONVERTASE at high level. The smaller fragment C3a is an ANAPHYLATOXIN and mediator of local inflammatory process. The larger fragment C3b binds with C3 convertase to form C5 convertase. C3 Complement,C3 Precursor,Complement 3,Complement C3 Precursor,Complement Component 3,Precursor-Complement 3,Pro-C3,Pro-Complement 3,C3 Precursor, Complement,C3, Complement,Complement, C3,Component 3, Complement,Precursor Complement 3,Precursor, C3,Precursor, Complement C3,Pro C3,Pro Complement 3
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000706 Anaphylatoxins Serum peptides derived from certain cleaved COMPLEMENT PROTEINS during COMPLEMENT ACTIVATION. They induce smooth MUSCLE CONTRACTION; mast cell HISTAMINE RELEASE; PLATELET AGGREGATION; and act as mediators of the local inflammatory process. The order of anaphylatoxin activity from the strongest to the weakest is C5a, C3a, C4a, and C5a des-arginine. Anaphylatoxin
D000907 Antibodies, Bacterial Immunoglobulins produced in a response to BACTERIAL ANTIGENS. Bacterial Antibodies
D015926 Complement C3a The smaller fragment generated from the cleavage of complement C3 by C3 CONVERTASE. C3a, a 77-amino acid peptide, is a mediator of local inflammatory process. It induces smooth MUSCLE CONTRACTION, and HISTAMINE RELEASE from MAST CELLS and LEUKOCYTES. C3a is considered an anaphylatoxin along with COMPLEMENT C4A; COMPLEMENT C5A; and COMPLEMENT C5A, DES-ARGININE. C3a Complement,Complement 3a,Complement Component 3a,C3a, Complement,Complement, C3a,Component 3a, Complement

Related Publications

E Bernatowska, and P Jose, and H Davies, and M Stephenson, and D Webster
November 2015, Molecular immunology,
E Bernatowska, and P Jose, and H Davies, and M Stephenson, and D Webster
February 1972, Biochimica et biophysica acta,
E Bernatowska, and P Jose, and H Davies, and M Stephenson, and D Webster
January 1986, Canadian journal of microbiology,
E Bernatowska, and P Jose, and H Davies, and M Stephenson, and D Webster
April 1975, The Journal of infectious diseases,
E Bernatowska, and P Jose, and H Davies, and M Stephenson, and D Webster
June 1989, Biochemical Society transactions,
E Bernatowska, and P Jose, and H Davies, and M Stephenson, and D Webster
June 1986, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
E Bernatowska, and P Jose, and H Davies, and M Stephenson, and D Webster
January 1986, Annali Sclavo. Collana monografica,
E Bernatowska, and P Jose, and H Davies, and M Stephenson, and D Webster
September 1974, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme,
E Bernatowska, and P Jose, and H Davies, and M Stephenson, and D Webster
August 2010, Current opinion in microbiology,
Copied contents to your clipboard!